• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Uxin Limited

    7/16/25 8:30:19 AM ET
    $UXIN
    Real Estate
    Real Estate
    Get the next $UXIN alert in real time by email
    S-8 1 forms-8.htm S-8

     

    As filed with the Securities and Exchange Commission on July 16, 2025

     

    Registration No. 333-______

     

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    FORM S-8

    REGISTRATION STATEMENT
    UNDER
    THE SECURITIES ACT OF 1933

     

     

     

    UXIN Limited

    (Exact name of registrant as specified in its charter)

     

    Cayman Islands   Not Applicable
    (State or other jurisdiction of
    incorporation or organization)
      (I.R.S. Employer
    Identification No.)

     

    Uxin Limited

    21/F, Donghuang Building
    No. 16 Guangshun South Avenue
    Chaoyang District, Beijing 100102
    People’s Republic of China
    +86 10 5691-6765

    (Address, Including Zip Code, and Telephone Number, Including Area Code, of registrant’s Principal Executive Offices)

     

     

     

    2018 FOURTH AMENDED AND

    RESTATED SHARE INCENTIVE

    PLAN

    (Full title of the plans)

     

     

     

    Cogency Global Inc.
    122 East 42nd Street, 18th Floor,
    New York, NY 10168
    (212) 947-7200

    (Name, address and telephone number, including area code, of agent for service)

     

     

     

      Copies to:  
    Feng Lin
    Chief Financial Officer
    Uxin Limited
    21/F, Donghuang Building
    No. 16 Guangshun South Avenue
    Chaoyang District, Beijing 100102
    People’s Republic of China
    +86 10 5691-6765
      Li He, Esq.
    Davis Polk & Wardwell LLP
    c/o 10th Floor,
    The Hong Kong Club building,
    3A Chater Road, Central
    Hong Kong
    +852 2533-3300

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

     

    Large accelerated filer ☐   Accelerated filer ☐
    Non-accelerated filer ☒ (Do not check if a smaller reporting company)   Smaller reporting company ☐
        Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

     

     

     

     
     

     

    Part I

    Information Required in the Section 10(A) Prospectus

     

    Item 1. Plan Information1

     

    Item 2. Registrant Information and Employee Plan Annual Information1

     

    Part II
    Information Required in the Registration Statement

     

    Item 3. Incorporation of Documents by Reference

     

    The following documents previously filed with the Securities and Exchange Commission (the “Commission”) by the Registrant are incorporated herein by reference.

     

    (1) The Registrant’s transition report on Form 20-F for the fiscal year ended December 31, 2024 filed on April 30, 2025 pursuant to Section 13(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”); and

     

    (2) The description of the Registrant’s Class A ordinary shares incorporated by reference to Exhibit 3.1 of the annual report on Form 20-F filed by the Registrant with the Securities and Exchange Commission on May 12, 2020, including any amendment and report subsequently filed for the purpose of updating that description.

     

    All documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior to the filing of a post-effective amendment which indicates that all securities offered have been sold, or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be a part hereof from the date of filing of such documents.

     

    Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein, or in any other subsequently filed document which also is incorporated or deemed to be incorporated by reference herein, modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

     

    Item 4. Description of Securities

     

    Not applicable.

     

    Item 5. Interest of Named Experts and Counsel

     

    Not applicable.

     

    Item 6. Indemnification of Directors and Officers

     

    Cayman Islands law does not limit the extent to which a company’s articles of association may provide for indemnification of officers and directors, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against civil fraud or the consequences or committing a crime. The Registrant’s amended and restated articles of association, adopted by its shareholders on June 1, 2018, provide that the Registrant shall indemnify each of its directors and officers against all actions, proceedings, costs, charges, expenses, losses, damages or liabilities incurred or sustained by such indemnified person, other than by reason of such person’s own dishonesty, willful default or fraud, in or about the conduct of the Registrant’s business or affairs (including as a result of any mistake of judgment) or in the execution or discharge of his duties, powers, authorities or discretions, including without prejudice to the generality of the foregoing, any costs, expenses, losses or liabilities incurred by such indemnified person in defending (whether successfully or otherwise) any civil proceedings concerning the Registrant or its affairs in any court whether in the Cayman Islands or elsewhere.

     

     

    1 Information required by Part I to be contained in the Section 10(a) prospectus is omitted from this Registration Statement in accordance with Rule 428 under the Securities Act and the Note to Part I of Form S-8. The documents containing information specified in this Part I will be separately provided to the participants in the Plan covered by this Registration Statement, as specified by Rule 428(b)(1) under the Securities Act.

     

     
     

     

    Pursuant to the indemnification agreements, the form of which was filed as Exhibit 10.2 to the Registrant’s registration statement on Form F-1, as amended (File No. 333-225266), the Registrant has agreed to indemnify its directors and executive officers against certain liabilities and expenses incurred by such persons in connection with claims made by reason of their being such a director or officer.

     

    The Underwriting Agreement, the form of which was filed as Exhibit 1.1 to the Registrant’s registration statement on Form F-1, as amended (File No. 333-225266), also provides for indemnification by the underwriters of the Registrant and its directors and officers for certain liabilities, including liabilities arising under the Securities Act, but only to the extent that such liabilities are caused by information relating to the underwriters furnished to the Registrant in writing expressly for use in such registration statement and certain other disclosure documents.

     

    Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling the Registrant pursuant to the foregoing provisions, the Registrant has been informed that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.

     

    The Registrant also maintains a directors and officers liability insurance policy for its directors and officers.

     

    Item 7. Exemption From Registration Claimed

     

    Not applicable.

     

    Item 8. Exhibits

     

    The Exhibits listed on the accompanying Exhibit Index are filed as a part of, or incorporated by reference into, this Registration Statement (See Exhibit Index below).

     

    Item 9. Undertakings

     

    (a) The undersigned Registrant hereby undertakes:

     

    (1) To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

     

    (i) To include any prospectus required by Section 10(a)(3) of the Securities Act;

     

    (ii) To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement; and

     

    (iii) To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement;

     

    provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the Registration Statement.

     

    (2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

     

     
     

     

    (3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

     

    (b) The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

     

    (c) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

     

    Exhibit Index

     

    Exhibit Number

     

    Description of Exhibit

    4.1  

    Amended and Restated Memorandum and Articles of Association of the Registrant (incorporated by reference to Exhibit 3.2 of the registration statement on Form F-1/A (file no. 333-225266), as amended, filed by the Registrant with the Securities and Exchange Commission on June 1, 2018)

         
    4.2   Registrant’s Specimen Certificate for Ordinary Shares (incorporated by reference to Exhibit 4.2 of the registration statement on Form F-1/A (file no. 333-225266), as amended, filed by the Registrant with the Securities and Exchange Commission on June 13, 2018)
         
    4.3   Deposit Agreement, among the Registrant, the depositary and the holders and beneficial owners of American Depositary Shares issued thereunder dated June 27, 2018 (incorporated by reference to Exhibit 4.3 of the registration statement on Form S-8 (file no. 333-227576), filed by the Registrant with the Securities and Exchange Commission on September 28, 2018)
         
    5.1   Opinion of Maples and Calder (Hong Kong) LLP (filed herewith)
         
    10.1   2018 Fourth Amended and Restated Share Incentive Plan (filed herewith)
         
    23.1   Consent of Maples and Calder (Hong Kong) LLP (included in Exhibit 5.1)
         
    23.2   Consent of PricewaterhouseCoopers Zhong Tian LLP (filed herewith)
         
    24.1   Power of Attorney (included on the signature page of this Registration Statement)
         
    107   Filing Fee Table (filed herewith)

     

     
     

     

    Signatures

     

    Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Beijing, China, on July 16, 2025.

     

      Uxin Limited
       
      By: /s/ Kun Dai
      Name: Kun Dai
      Title: Chairman of the Board of Directors and Chief Executive Officer

     

     
     

     

    Power of Attorney

     

    Each person whose signature appears below constitutes and appoints Mr. Kun Dai and Mr. Feng Lin, as his true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution, for him and in his name, place, and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments, exhibits thereto and other documents in connection therewith) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his substitute, may lawfully do or cause to be done by virtue hereof.

     

    Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities indicated on July 16, 2025.

     

      By: /s/ Kun Dai
      Name: Kun Dai
      Title: Chairman of the Board and Chief Executive Officer
       
      By: /s/ Bin Li
      Name: Bin Li
      Title: Director
       
      By: /s/ Erhai Liu
      Name: Erhai Liu
      Title: Director
       
      By: /s/ Cheng Lu
      Name: Cheng Lu
      Title: Independent Director
       
      By: /s/ Li Ying
      Name: Li Ying
      Title: Independent Director
         
      By: /s/ John Zhuang Yang
      Name: John Zhuang Yang
      Title: Independent Director

     

     
     

     

    Signature of Authorized Representative in the United States

     

    Pursuant to the Securities Act of 1933, the undersigned, the duly authorized representative in the United States of Uxin Limited, has signed this registration statement or amendment thereto in New York on July 16, 2025.

     

     

    Authorized U.S. Representative

       
      Cogency Global Inc.
       
      By: /s/ Colleen A. De Vries
      Name: Colleen A. De Vries
      Title: Senior Vice President on behalf of Cogency Global Inc.

     

     

     

    Get the next $UXIN alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $UXIN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $UXIN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Presenting on Emerging Growth Conference 84 Day 2 on July 17; Register to live stream

    MIAMI, July 16, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 84th Emerging Growth Conference on July 16 & 17, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: [email protected] For updates, follow us on Twitter Day 1 – Presenting Today, July 16, 2025 8:45Virtual Lobby opens.Register for the Conference. If you already registered, go

    7/16/25 7:00:00 AM ET
    $ADVM
    $ASPI
    $BNZI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Major Chemicals
    Industrials

    Presenting on Emerging Growth Conference 84 Day 1 on July 16; Register to live stream

    MIAMI, July 15, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 84th Emerging Growth Conference on July 16 & 17, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: [email protected] For updates, follow us on Twitter Day 1July 16, 2025 8:45Virtual Lobby opens.Register for the Conference. If you already registered, go back to the registra

    7/15/25 7:00:00 AM ET
    $ADVM
    $ASPI
    $BNZI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Major Chemicals
    Industrials

    Uxin to Present at the Emerging Growth Conference on July 17, 2025

    BEIJING, July 11, 2025 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company") (NASDAQ:UXIN), China's leading used car retailer, is pleased to announce that it has been invited to present at the upcoming Emerging Growth Conference. Date: July 17th, 2025Time: 9:40 – 10:10 a.m. ETRegistration Link:  https://goto.webcasts.com/starthere.jsp?ei=1717085&tp_key=408af67859&sti=uxin Uxin cordially invites individual and institutional investors as well as advisors and analysts to attend its real-time, interactive presentation at the Emerging Growth Conference. Mr. Feng Lin, Chief Financial Officer of Uxin, will give a presentation and subsequently open the floor for questions. Investors, analysts and

    7/11/25 8:00:00 AM ET
    $UXIN
    Real Estate

    $UXIN
    SEC Filings

    View All

    SEC Form EFFECT filed by Uxin Limited

    EFFECT - Uxin Ltd (0001729173) (Filer)

    8/6/25 12:15:06 AM ET
    $UXIN
    Real Estate

    Amendment: SEC Form F-3/A filed by Uxin Limited

    F-3/A - Uxin Ltd (0001729173) (Filer)

    7/28/25 8:15:40 AM ET
    $UXIN
    Real Estate

    Amendment: SEC Form F-3/A filed by Uxin Limited

    F-3/A - Uxin Ltd (0001729173) (Filer)

    7/16/25 4:06:03 PM ET
    $UXIN
    Real Estate

    $UXIN
    Leadership Updates

    Live Leadership Updates

    View All

    Missfresh Limited Announces Appointment of New Independent Director and Changes to Board Composition

    BEIJING, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Missfresh Limited ("Missfresh" or the "Company") (NASDAQ:MF), an innovator and leader in China's neighborhood retail industry, today announced the Company's board of directors (the "Board") has approved the appointment of Mr. Shun Lam Steven Tang as an independent director of the Company and the following changes to the Board's composition, effective immediately. Mr. Shun Lam Steven Tang has been appointed as a member of the audit committee of the Board, a member of the compensation committee of the Board, and the chairman of the nominating and corporate governance committee of the Board.Mr. Hansong Zhu has been appointed as the chairman of the c

    8/16/21 6:00:00 AM ET
    $UXIN
    Real Estate

    $UXIN
    Financials

    Live finance-specific insights

    View All

    Uxin Reports Unaudited Financial Results for the Quarter Ended March 31, 2025

    BEIJING, June 12, 2025 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company") (NASDAQ:UXIN), China's leading used car retailer, today announced its unaudited financial results for the quarter ended March 31, 2025. Highlights for the Quarter Ended March 31, 2025 Transaction volume was 8,264 units for the three months ended March 31, 2025, a decrease of 12.4% from 9,439 units in the last quarter and an increase of 103.6% from 4,058 units in the same period last year.Retail transaction volume was 7,545 units, a decrease of 11.8% from 8,554 units in the last quarter and an increase of 141.5% from 3,124 units in the same period last year.Total revenues were RMB504.2 million (US$69.5 million) for

    6/12/25 4:50:00 AM ET
    $UXIN
    Real Estate

    Uxin to Report First Quarter 2025 Financial Results on June 12, 2025

    BEIJING, June 6, 2025 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company") (NASDAQ:UXIN), China's leading used car retailer, today announced that it will release its financial results for the first quarter 2025 ended March 31, 2025, before the U.S. market opens on June 12, 2025. Uxin's management team will host a conference call on Thursday, June 12, 2025, at 8:00 A.M. U.S. Eastern Time (8:00 P.M. Beijing/Hong Kong time on the same day) to discuss the financial results. In advance of the conference call, all participants must use the following link to complete the online registration process. Upon registering, each participant will receive access details for this conference including an e

    6/6/25 7:50:00 AM ET
    $UXIN
    Real Estate

    Uxin Reports Unaudited Financial Results for the Quarter and Full Year Ended December 31, 2024

    BEIJING, April 30, 2025 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company") (NASDAQ:UXIN), China's leading used car retailer, today announced its unaudited financial results for the quarter and full year ended December 31, 2024. As previously announced on November 25, 2024, the Company's board of directors approved a change in the Company's fiscal year end from March 31 to December 31, effective for the fiscal year beginning January 1, 2024. Accordingly, references in this release to the "full year of 2024" and the "full year ended December 31, 2024" denote the twelve-month period from January 1 to December 31, 2024, while the "fourth quarter of 2024" and the "quarter ended December 31, 2

    4/30/25 3:30:00 AM ET
    $UXIN
    Real Estate

    $UXIN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Uxin Limited

    SC 13D/A - Uxin Ltd (0001729173) (Subject)

    11/6/24 4:05:24 PM ET
    $UXIN
    Real Estate

    Amendment: SEC Form SC 13G/A filed by Uxin Limited

    SC 13G/A - Uxin Ltd (0001729173) (Subject)

    10/23/24 7:44:31 PM ET
    $UXIN
    Real Estate

    SEC Form SC 13G/A filed by Uxin Limited (Amendment)

    SC 13G/A - Uxin Ltd (0001729173) (Subject)

    4/30/24 3:15:42 PM ET
    $UXIN
    Real Estate